Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, FibroBiologics Inc’s stock clocked out at $0.22, down -7.03% from its previous closing price of $0.24. In other words, the price has decreased by -$7.03 from its previous closing price. On the day, 21.5 million shares were traded. FBLG stock price reached its highest trading level at $0.2687 during the session, while it also had its lowest trading level at $0.2212.
Ratios:
To gain a deeper understanding of FBLG’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.78 and its Current Ratio is at 0.78. In the meantime, Its Debt-to-Equity ratio is 59.25 whereas as Long-Term Debt/Eq ratio is at 15.83.
Upgrades & Downgrades
In the most recent recommendation for this company, Rodman & Renshaw on December 12, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.
On September 24, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $12.Maxim Group initiated its Buy rating on September 24, 2024, with a $12 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 11 ’25 when GARCIA RUBEN A bought 140,000 shares for $0.34 per share. The transaction valued at 47,600 led to the insider holds 140,000 shares of the business.
Khoja Hamid bought 20,000 shares of FBLG for $16,800 on May 27 ’25. The Chief Scientific Officer now owns 31,250 shares after completing the transaction at $0.84 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBLG now has a Market Capitalization of 14960286 and an Enterprise Value of 13818472.
Stock Price History:
The Beta on a monthly basis for FBLG is -0.57, which has changed by -0.8938679 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, FBLG has reached a high of $2.39, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -29.34%, while the 200-Day Moving Average is calculated to be -64.59%.
Shares Statistics:
It appears that FBLG traded 1.47M shares on average per day over the past three months and 3650950 shares per day over the past ten days. A total of 66.52M shares are outstanding, with a floating share count of 56.55M. Insiders hold about 14.99% of the company’s shares, while institutions hold 8.11% stake in the company. Shares short for FBLG as of 1765756800 were 795335 with a Short Ratio of 0.54, compared to 1763078400 on 1410801. Therefore, it implies a Short% of Shares Outstanding of 795335 and a Short% of Float of 1.4400001.
Earnings Estimates
The stock of FibroBiologics Inc (FBLG) is currently drawing attention from 2.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.48 and -$0.49 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.41, with 2.0 analysts recommending between -$0.38 and -$0.45.
